Objective We evaluated the efficacy and safety of deep brain anterior thalamus stimulation
after 7 and 10 years, and report the incidence of sudden unexpected death in epilepsy …

Objective The risk of premature death is increased in patients with intractable epilepsy. The
effect of vagus nerve stimulation (VNS) on mortality remains unclear. In a previous study by …

Objective: To report long-term efficacy and safety results of the SANTE trial investigating
deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of …

Background and Objectives The efficacy of deep brain stimulation of the anterior nucleus of
the thalamus (ANT DBS) in patients with drug-resistant epilepsy (DRE) was demonstrated in …

Objective Limited data are available regarding the evolution over time of the rate of sudden
unexpected death in epilepsy patients (SUDEP) in drug‐resistant epilepsy. The objective is …

Purpose: This report concerns the 2‐year extension of the study of mortality and sudden,
unexpected, unexplained death in epilepsy (SUDEP) in the cohort of patients receiving …

Neuromodulation is a key therapeutic tool for clinicians managing patients with drug‐
resistant epilepsy. Multiple devices are available with long‐term follow‐up and real‐world …

Objective: To determine the incidence rates of sudden unexpected death in epilepsy
(SUDEP) in different epilepsy populations and address the question of whether risk factors …

Purpose: To determine rates of all‐cause mortality and of sudden, unexpected, unexplained
deaths in epilepsy (SUDEP) in a cohort of individuals treated with the Neuro Cybernetic …

Purpose Anterior thalamic deep brain stimulation (ATN DBS) is an emerging, effective
treatment for patients with drug-resistant epilepsy, but long-term results on its efficacy and …